Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate
Hafsia Abbas1, Dalia Kheira Derkaoui1, Louise Jeammet2
1Université Oran 1, Ahmed Ben Bella, Oran 31000, Algeria.
Abstract:
Apoptosis, or programmed cell death, is a fundamental process that maintains tissue homeostasis, eliminates damaged or infected cells, and plays a crucial role in various biological phenomena. The deregulation of apoptosis is involved in many human diseases, including cancer. One of the emerging players in the intricate regulatory network of apoptosis is apoptosis inhibitor 5 (API5), also called AAC-11 (anti-apoptosis clone 11) or FIF (fibroblast growth factor-2 interacting factor). While it may not have yet the same level of notoriety as some other cancer-associated proteins, API5 has garnered increasing attention in the cancer field in recent years, as elevated API5 levels are often associated with aggressive tumor behavior, resistance to therapy, and poor patient prognosis. This review aims to shed light on the multifaceted functions and regulatory mechanisms of API5 in cell fate decisions as well as its interest as therapeutic target in cancer.
Insights
Apoptosis inhibitor 5 (API5) is a key regulator of programmed cell death implicated in cancer. Elevated API5 levels correlate with aggressive tumors and poor prognosis, highlighting its therapeutic potential.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- Apoptosis, or programmed cell death, is vital for tissue homeostasis and eliminating aberrant cells.
- Dysregulation of apoptosis contributes to human diseases, notably cancer.
- Apoptosis inhibitor 5 (API5) is an emerging regulator in the apoptosis network, increasingly linked to cancer progression.
Purpose of the Study:
- To review the multifaceted functions and regulatory mechanisms of API5 in cell fate.
- To explore the significance of API5 as a potential therapeutic target in cancer.
Main Methods:
- Literature review of studies on API5.
- Analysis of API5's role in apoptosis regulation.
- Examination of API5's association with cancer aggressiveness and therapeutic resistance.
Main Results:
- API5 plays a complex role in regulating apoptosis.
- Increased API5 expression is associated with aggressive tumor phenotypes.
- Elevated API5 levels predict poor patient outcomes and resistance to cancer therapies.
Conclusions:
- API5 is a critical factor in cancer development and progression.
- Targeting API5 presents a promising therapeutic strategy for cancer treatment.
Related Concept Videos
Apoptosis
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Caspases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...


